Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Mattia Arrigo , Petra Nijst , Alain Rudiger Added: 3 years ago
Heart failure is a clinical syndrome induced by cardiac abnormalities resulting in reduced cardiac output and/or elevated intra-cardiac end-diastolic pressures and causing symptoms that are often accompanied by typical physical signs.1 Demographic changes, improved treatment of several acute cardiac disorders, such myocardial infarction, arrhythmia and congenital heart disease, and increased long… View more

Heart Failure
Congestion and Diuretic Resistance in Acute or Worsening Heart Failure
Author(s): Ingibjörg Kristjánsdóttir , Tonje Thorvaldsen , Lars H Lund Added: 3 years ago
From Acute Heart Failure Towards Worsening or De Novo Heart Failure The natural history of heart failure (HF) is characterised by disease progression and episodes of worsening HF and acute decompensation requiring outpatient treatment intensification, emergency department or in-hospital care. Acute HF (AHF), also known as acute decompensated HF, is defined as a progressive and sometimes rapid… View more

Heart Failure
De Novo HF Versus ADCHF
Author(s): Wilson Matthew Raffaello , Joshua Henrina , Ian Huang , et al Added: 3 years ago

Heart Failure
Optimising Treatment Of Heart Failure
Author(s): Frank Ruschitzka , John JV McMurray , John R Teerlink Added: 6 years ago
Summary This Satellite Symposium - Experts on the Spot session titled ‘Optimising treatment of heart failure – where are we today?’ was moderated by Frank Ruschitzka. This session provided delegates the opportunity to ask questions to the expert faculty panelists; John McMurray and John Teerlink, following the two Novartis-sponsored Satellite Symposia on acute and chronic heart failure at ESC… View more

Heart Failure
e-SPACE Heart Failure 2023
Author(s): Stefan Anker , Giuseppe Rosano , Javier de Juan Bagudá , et al Added: 5 months ago
Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology were delighted to announce the return of e-SPACE Heart Failure 2023. A thoughtfully curated programme supported the exploration of how leading experts are implementing the new heart failure guidelines into clinical practice and showed the latest information on patient profiling in heart failure for tailoring… View more

Heart Failure

Prevention & Chronic Conditions
ACC 22: Results From the EMPULSE Study
Author(s): Mikhail Kosiborod Added: 2 years ago
In this short interview, Dr Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, US) summarises the main findings of the EMPULSE study, originally presented as a late-breaking trial at ACC.22(NCT04157751). The study investigated the effects of empagliflozin on symptoms,physical limitations and quality of life inacute heart failure. The trial demonstrated that treatment with empagliflozin… View more

Heart Failure
Novartis sponsored Satellite Symposium at Heart Failure 2018 Congress
Author(s): Frank Ruschitzka Start date: May 27, 2018
Sunday 27 May: Satellite Symposium → Sunday 27 May: Satellite Symposium – Experts on the Spot → Please note this content is not intended for healthcare professionals licensed in the USA. Please use Internet Explorer or Firefox browser to view the Live Stream --> Novartis sponsored Satellite Symposium at Heart Failure 2018 Congress Resolving dilemmas in the treatment of heart failure … View more

Heart Failure
Jozine ter Maaten
Research Area(s) / Expertise:

Heart Failure

 Job title: Cardiologist
Dr Jozine ter Maaten is a cardiologist at the University Medical Center Groningen, specializing in acute heart failure. Her research focuses on understanding congestion and improving diuretic response and outcomes in patients with this condition. Dr ter Maaten completed her PhD on 'Diuretic response and renal biomarkers in heart failure' in 2016 and has since been actively involved in research… View more
Kevin Damman
Research Area(s) / Expertise:

Heart Failure

Imaging & Diagnostics

 Job title: Head of the Heart Transplant and Left Ventricular Device Program
Dr Kevin Damman is Head of the Heart Transplant and Left Ventricular Device Program at the University Medical Center Groningen in the Netherlands. His research interests focus on acute and advanced heart failure, including cardiorenal axis. He is also interested in improving the treatment of acute heart failure patients, with early assessment of decongestive therapies, SGLT2 inhibitors in… View more
Haemodynamic Balance in Acute and Advanced Heart Failure: An Expert Perspective on the Role of Levosimendan
Author(s): Piergiuseppe Agostoni , Dimitrios T Farmakis , Jose M García-Pinilla , et al Added: 3 years ago
The use of IV vasoactive drugs, diuretics, vasodilators and inotropes for correcting haemodynamic dysfunction in patients with decompensated heart failure has been described over many decades.1 However, data on their effects on prognosis do not offer a convincing picture of clinical benefit.2 This is particularly true regarding IV inotropes. Clinical data collected on the effects of cardiac… View more

Heart Failure